Brief: Sinomab BioScience Says Proposed Issue Of HK$100 Mln Convertible Bonds Due 2022
22/12/2020 15:37
Dec 22 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* ISSUE PRICE OF HK$5.0 FOR EACH CONVERSION SHARE
Source text for Eikon: ID:nHKS9KTr2C
Further company coverage: 3681.HK
(Reporting by Yamini C S)
((Yamini.CS@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience